A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Academic Article uri icon

Overview

publication date

  • March 1, 2004

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Cancer Vaccines
  • Clinical Trials, Phase I as Topic
  • Cyclophosphamide
  • Doxorubicin
  • Granulocyte-Macrophage Colony-Stimulating Factor

Identity

Scopus Document Identifier

  • 12144287913

Digital Object Identifier (DOI)

  • 10.1089/104303404322886165

PubMed ID

  • 15018740

Additional Document Info

volume

  • 15

issue

  • 3